Literature DB >> 18436836

Mapping of the neonatal Fc receptor in the rodent eye.

Hyuncheol Kim1, Robert N Fariss, Connie Zhang, Shaun B Robinson, Michelle Thill, Karl G Csaky.   

Abstract

PURPOSE: The neonatal Fc receptor (FcRn) has been known to modulate IgG transport and protect against IgG catabolism, resulting in extension of the serum half-life of IgG. The goal of this study was to localize FcRn receptor expression in the rat's eye.
METHODS: The cornea, retina, conjunctiva, ciliary body and iris, retinal pigment epithelium and choroid, and lens were dissected from each rat's eye, and total RNA was purified. The first-strand cDNAs were synthesized and subjected to PCR reaction. For control samples, reverse transcriptase was omitted. A monoclonal antibody against the FcRn heavy chain was used to localize the distribution of the FcRn receptor in ocular tissues. Lymphatic vessels and blood vessels were stained with a rabbit anti-mouse lymphatic vessel endothelial receptor-1 polyclonal antibody and a rabbit anti-human von Willebrand factor polyclonal antibody, respectively.
RESULTS: RT-PCR demonstrated expression of FcRn RNA in cornea, retina, conjunctiva, ciliary body and iris, and lens but absence of expression in the retinal pigment epithelium and choroid. Immunohistochemistry and double staining confirmed the expression of FcRn receptor to the conjunctival lymphatic vessels but not in the conjunctival blood vessels. In the ciliary body, the FcRn receptor was found to be expressed in both the nonpigmented ciliary epithelium and the ciliary blood vessels. The expression of FcRn receptor was confirmed in the retinal blood vessels, iris blood vessels, optic nerve vascular structures, corneal epithelium and endothelium, and lens epithelium.
CONCLUSIONS: The FcRn receptor is expressed in multiple ocular tissues. The blood-ocular barrier showed FcRn receptor expression, indicating that IgG transport from ocular tissues to the blood system may use this receptor. The role of the FcRn receptor in the anterior segment and the conjunctiva remains unclear.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436836      PMCID: PMC3950474          DOI: 10.1167/iovs.07-0871

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

1.  A novel Fc gamma R-defined, IgG-containing organelle in placental endothelium.

Authors:  Toshihiro Takizawa; Clark L Anderson; John M Robinson
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

2.  Identification and function of neonatal Fc receptor in mammary gland of lactating mice.

Authors:  P Cianga; C Medesan; J A Richardson; V Ghetie; E S Ward
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

3.  The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.

Authors:  R P Junghans; C L Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

4.  A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes.

Authors:  R S Blumberg; T Koss; C M Story; D Barisani; J Polischuk; A Lipin; L Pablo; R Green; N E Simister
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

5.  Crystal structure of the complex of rat neonatal Fc receptor with Fc.

Authors:  W P Burmeister; A H Huber; P J Bjorkman
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

6.  Blood-eye barriers in the rat: correlation of ultrastructure with function.

Authors:  P A Stewart; U I Tuor
Journal:  J Comp Neurol       Date:  1994-02-22       Impact factor: 3.215

7.  IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.

Authors:  Rashid Deane; Abhay Sagare; Katie Hamm; Margaret Parisi; Barbra LaRue; Huang Guo; Zhenhua Wu; David M Holtzman; Berislav V Zlokovic
Journal:  J Neurosci       Date:  2005-12-14       Impact factor: 6.167

Review 8.  Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions.

Authors:  Ken-ichi Hosoya; Masatoshi Tomi
Journal:  Biol Pharm Bull       Date:  2005-01       Impact factor: 2.233

Review 9.  Fc receptors and their interactions with immunoglobulins.

Authors:  M Raghavan; P J Bjorkman
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

10.  LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.

Authors:  S Banerji; J Ni; S X Wang; S Clasper; J Su; R Tammi; M Jones; D G Jackson
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

View more
  26 in total

1.  Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: the eye.

Authors:  Na Niu; Jie Zhang; Yingui Sun; Shuna Wang; Yonghong Sun; Christine Korteweg; Weiwei Gao; Jiang Gu
Journal:  Cell Mol Life Sci       Date:  2011-07       Impact factor: 9.261

2.  Distribution of FcRn Across Species and Tissues.

Authors:  Sari Latvala; Bjoern Jacobsen; Michael B Otteneder; Annika Herrmann; Sven Kronenberg
Journal:  J Histochem Cytochem       Date:  2017-04-12       Impact factor: 2.479

Review 3.  Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn.

Authors:  Kristi Baker; Shuo-Wang Qiao; Timothy Kuo; Kanna Kobayashi; Masaru Yoshida; Wayne I Lencer; Richard S Blumberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

Review 4.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

5.  Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells.

Authors:  Ying Hu; Seongeun Cho; Jeffrey L Goldberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-29       Impact factor: 4.799

Review 6.  Therapeutic antibodies in ophthalmology: old is new again.

Authors:  Charlotte Magdelaine-Beuzelin; Coralie Pinault; Gilles Paintaud; Hervé Watier
Journal:  MAbs       Date:  2010 Mar-Apr       Impact factor: 5.857

Review 7.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

8.  Expression of neonatal Fc receptor in the eye.

Authors:  Michael B Powner; Jenny A G McKenzie; Gregory J Christianson; Derry C Roopenian; Marcus Fruttiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

Review 9.  Neonatal Fc receptor: from immunity to therapeutics.

Authors:  Timothy T Kuo; Kristi Baker; Masaru Yoshida; Shuo-Wang Qiao; Victoria G Aveson; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Immunol       Date:  2010-10-01       Impact factor: 8.317

10.  FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.

Authors:  Hyuncheol Kim; Shaun B Robinson; Karl G Csaky
Journal:  Mol Vis       Date:  2009-12-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.